BNTC·08205P209·US·equity·Healthcare - Biotechnology-Activist
BNTC (BENITEC BIOPHARMA INC) is held by 54 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($30.7M), FRANKLIN RESOURCES INC ($25.3M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($22.6M). Net institutional sentiment: Bullish.
See how BNTC's score breaks down across 4 SEC sources
Showing 1-20 of 58
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer